Mobile

Localized gastrointestinal stromal tumors (GIST): an exploratory open-label, multicenter, single-arm phase II study to evaluate the efficacy of 2 years of adjuvant nilotinib treatment following at lea...

Mise à jour : Il y a 4 ans
Référence : EUCTR2010-022713-26

Localized gastrointestinal stromal tumors (GIST): an exploratory open-label, multicenter, single-arm phase II study to evaluate the efficacy of 2 years of adjuvant nilotinib treatment following at least 1 year of adjuvant imatinib mesylate

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate the activity of nilotinib in patients with localized GIST who have undergone R0 or R1 resection and who have been treated with imatinib for at least 12 months in an adjuvant setting.

Critère d'inclusion

  • localized gastrointestinal stromal tumors (GIST)

Liens